Jacobs Levy Equity Management, Inc Mimedx Group, Inc. Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.97 - $4.81 $828,030 - $1.34 Million	-278,798 Reduced 90.24%	30,168 $102,000
Q4 2022 Feb 14, 2023	SELL	$2.63 - $3.45 $578,702 - $759,134	-220,039 Reduced 41.59%	308,966 $858,000
Q3 2022 Nov 15, 2022	BUY	$2.71 - $4.22 $592,281 - $922,297	218,554 Added 70.4%	529,005 $1.52 Million
Q2 2022 Aug 15, 2022	SELL	$3.17 - $5.0 $497,243 - $784,295	-156,859 Reduced 33.57%	310,451 $1.08 Million
Q1 2022 May 16, 2022	BUY	$4.27 - $6.27 $517,020 - $759,184	121,082 Added 34.97%	467,310 $2.2 Million
Q4 2021 Feb 14, 2022	BUY	$5.7 - $8.48 $1.97 Million - $2.94 Million	346,228 New	346,228 $2.09 Million

208

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.03B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.